307 Results for “COVID 19”

Yale Law School Fellow Stephen Roach, discusses his just-released book, Accidental Conflict. Roach explores how much of the adversarial nationalist rhetoric in both China and the USA is dangerously misguided and more a reflection of each nation’s fears and vulnerabilities than a credible assessment of the risks they face.

Historians Naomi Oreskes (Harvard University) and Erik Conway (Caltech) talk to Rob about their just released book, The Big Myth: How American Business Taught Us to Loathe Government and Love the Free Market.

Martín Guzmán, ex ministro de Economía de Argentina, explica cómo el rol del poder debe ser central en la investigación económica, especialmente cuando se trata de deuda soberana.

Patrick Bond, sociology professor at the University of Johannesburg, South Africa, discusses the urgent need for climate reparations for Africa, in light of the COP26 climate summit, and why market solutions will not work to address the problems Africa is currently facing. Part 1 of 2.

Financial Times Asia editor Jamil Anderlini talks to Rob about the lasting legacy of the Opium Wars on Chinese foreign policy, and the future of Hong Kong.

Entretien avec Gilles Yabi, directeur exécutif du Think Tank ouest-africain WATHI, sur la sécurité alimentaire en Afrique

Reindustrialization vs Financialization

In a replay of INET Live’s webinar, following the COP26 climate conference in Glasgow last December, Richard Kozul-Wright of UNCTAD, Patrick Bond of the University of Johannesburg, and author Maude Barlow discuss the disproportionate impact climate change has on the developing world and the ways to best address it.

And electric vehicles don’t do a lot better

In Treasury markets, there are no libertarians, only grateful recipients of single-payer insurance for ailing financial markets.

Arjun Jayadev, economics professor at Azim Premji University in Bangalore, India, and Achal Prabhala, coordinator of the AccessIBSA project, discusses the urgency of waiving intellectual property protections for vaccines, particularly in light of the on-going COVID-19 pandemic in India and other developing countries.